GobyMeds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.3/10
Best for: moving between compounded and brand without changing seller
GobyMeds' strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
then $99/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked August 2026
GobyMeds is a low-cost telehealth seller. Compounded semaglutide is the only medication it offers.
Is GobyMeds legit?
Yes. GobyMeds is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 8.3/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a GobyMeds promo or coupon code?
GobyMeds has no coupon code to enter. New patients are currently quoted $93 for the first month, then $99 a month, and the discount applies on its own. Coupon sites advertising a "GobyMeds promo code" are not a source we can vouch for.
See how GobyMeds compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to GobyMeds
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
GobyMeds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide
- Starting price
- $99/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How GobyMeds scores
Six columns, each one computed from something GobyMeds has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
9.6/10$133/month is 47% below the $250 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on GobyMeds
Last checked August 2026- Checked the listed price across 10 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for GobyMeds
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with GobyMeds involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1GobyMeds shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask GobyMeds which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $99, tirzepatide $133. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that GobyMeds serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting GobyMeds
- Phone
- +1 866 785 9869
- GobyMeds offers email support
GLP-1 medications GobyMeds offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
$299 total for 12 weeks incl. medication, shipping, consultation, injection kit; JUMPSTART20 promo $279 total ($93/mo) — promo end-dated Dec 31 2025 but still displayed July 2026
$399 total / 12 weeks
$499 total / 12 weeks; JUMPSTART PROMO PRICE $439 ($146/month) shown under the higher-dose block
JUMPSTART20 promo $159
$399 total for 12 weeks incl. medication, shipping, consultation, injection kit; promo price shown unchanged at $399
$499 total / 12 weeks
$599 total / 12 weeks; JUMPSTART PROMO PRICE $479+ (price dependent on dose)
Primary pricing block says $299 (promo $279); a duplicated template block on the same page shows $349 — site inconsistency
Promo codes 'not valid on Zepbound and Wegovy'
Promo codes 'not valid on Zepbound and Wegovy'
Check the price yourself before you pay
Every figure here was read off GobyMeds's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $99 a month, 46% below the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $133 a month, 47% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to GobyMeds
Against it
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What GobyMeds charges
The figure GobyMeds leads with is $93, and it is a first-month rate. From month two the price is $99/month, which is the number to plan around. There is nothing wrong with an introductory offer; it just is not the price of staying on the medication.
- Compounded semaglutide: $93 first month, then $99/month
- Compounded semaglutide: $133/month
- Compounded semaglutide: $146 first month, then $166/month
- Compounded semaglutide: $159 first month, then $169/month
- Compounded tirzepatide: $133/month
- Compounded tirzepatide: $166/month
For compounded tirzepatide, the median across the sellers we compare is $250/month, so GobyMeds' $133 is genuinely below the middle, not just advertised that way.
bmiMD, at about $99/month, is the closest like-for-like alternative we review.
What GobyMeds dispenses
GobyMeds prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. Both routes are available: the FDA-approved pen, or a compounded version at lower cost. The difference is not cosmetic. The approved product has been reviewed for safety, efficacy and manufacturing quality, and a compounded preparation has not.
Safety and disclosure
GobyMeds tells you its price before you start the medical questionnaire. We found no FDA warning letters issued to GobyMeds. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If GobyMeds will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
- You need insurance to cover the cost. Check whether GobyMeds bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want a cheap way to find out whether the medication suits you before committing
Our read
GobyMeds is a cheap way to start and an ordinary way to continue. Use the $93 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $99/month before you let it renew twice.
The Bottom Line
GobyMeds' strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Before you pay GobyMeds
Starting at $93 a month. Check today's price, then start the intake.
Where GobyMeds is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider Sesame Care (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare GobyMeds head to head
The sellers closest to GobyMeds on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this GobyMeds review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See GobyMeds's current pricing
Plans start at $93 a month. Whether you qualify is a clinician's decision, made after your intake.